Dosage Form: capsule
Taron™-Prex Prenatal with DHA CAP
Rx Prenatal Vitamin
Rx Only
Taron-Prex Prenatal Description
Taron™-Prex Prenatal with DHA capsules are a prescription prenatal/postnatal multivitamin/mineral softgel capsule with fish oil-based DHA. Each softgel capsule is oblong, maroon and imprinted with "T543" in white ink.
- 1.2 mg Folic Acid and 265 mg DHA (key omega-3 fatty acid from purified fish oil)
- Essential vitamins and minerals
- Gentle stool softener
| Each softgel capsule contains: | |
|---|---|
| |
| Vitamin C (ascorbic acid, USP) | 25 mg |
| Calcium (tribasic calcium phosphate, NF) | 160 mg |
| Iron (ferrous fumarate, USP) | 30 mg |
| Vitamin D3 (cholecalciferol, USP) | 170 IU |
| Vitamin E (d-alpha tocopherol, USP) | 30 IU |
| Vitamin B6 (pyridoxine hydrochloride, USP) | 25 mg |
| Folic Acid, USP | 1.2 mg |
| DHA (Docosahexaenoic Acid) | 265 mg* |
| Docusate Sodium, USP | not more than 55 mg |
Inactive Ingredients: Gelatin, Soybean Oil, Glycerin, Purified Water, Lecithin, Yellow Bees Wax, Natural Orange Flavor, FD&C Red #40, Titanium Dioxide, Ethyl Vanillin, FD&C Yellow #6, FD&C Blue #1.
INDICATIONS
Taron™-Prex Prenatal with DHA capsules are indicated to provide vitamin/mineral and fish-based DHA supplementation throughout pregnancy, during the postnatal period for both lactating and non-lactating mothers, and throughout the childbearing years. Taron™-Prex Prenatal with DHA may be useful in improving the nutritional status of women prior to conception.
Contraindications
Taron™-Prex Prenatal with DHA capsules are contraindicated in patients with a known Hypersensitivity to any of the ingredients, including fish or fish oil. Do not take this product if you are presently taking mineral oil, unless directed by a doctor.
Warning
Ingestion of more than 3 grams of omega-3 fatty acids such as DHA) per day has been shown to have potential antithrombotic effects, including an increased bleeding time and International Normalized Ratio (INR). Administration of omega-3 fatty acids should be avoided in patients taking anticoagulants and in those known to have an inherited or acquired predisposition to bleeding.
WARNING
Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF THE REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.
THIS PRODUCT CONTAINS SOY AND FISH OIL.
PRECAUTION
Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias here vitamin B12 is deficient. Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive.
Adverse Reactions
Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
CAUTION
Exercise caution to ensure that the prescribed dosage of DHA does not exceed 1 gram (1000 mg) per day.
Taron-Prex Prenatal Dosage and Administration
Before, during and/or after pregnancy, one softgel capsule daily or as prescribed by a physician.
How is Taron-Prex Prenatal Supplied
Bottles of 30 softgel capsules
NDC 13811-543-30
STORAGE
Store at 20°-25°C (68°-77°F), excursions permitted to 15°-30°C (59°- 86°F) [See USP controlled room temperature].
KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN.
Call your doctor about side effects. You may report side effects by calling 888 9 TRIGEN (888-987-4436).
Rx Only
All prescriptions using this product shall be pursuant to state statutes as applicable. This is not an Orange Book product. There are no implied or explicit claims on therapeutic equivalence.
Manufactured For:
TRIGEN Laboratories, Inc.
Sayreville, NJ 08872
www.trigenlab.com
Rev. 06/11
PRINCIPAL DISPLAY PANEL - 30 Capsule Label
NDC 13811-543-30
Rx Only
Taron™-Prex Prenatal
with DHA CAP
RX PRENATAL VITAMIN
- 1.2 mg Folic Acid and 265 mg DHA
(key omega-3 fatty acid) - Essential vitamins and minerals
- Gentle stool softener
30 CAPSULES
TRIGEN
LABORATORIES
| TARON-PREX PRENATAL ascorbic acid, tribasic calcium phosphate, iron, cholecalciferol, alpha-tocopherol, pyridoxine hydrochloride, folic acid, doconexent, and docusate sodium capsule | |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| Marketing Information | |||
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| Unapproved drug other | 12/01/2009 | ||
| Labeler - TRIGEN Laboratories, Inc. (830479668) |
No comments:
Post a Comment